The germany in-vitro diagnostics market size is projected to expand at a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing private hospitals, independent testing laboratories, and the growing demand for instant testing and personalized medicine.
In vitro diagnostics are medical equipment, tests, and reagents that are used to diagnose health conditions. In addition, these instruments are also used to analyze tissue and body fluid samples collected from patients. In addition, there are different types of in vitro diagnosis using different methods, such as immunodiagnostic, tissue diagnosis, hematology, and molecular diagnosis. In addition, in-vitro diagnosis is used to diagnose various diseases, such as infectious diseases, cancer, heart, and kidney diseases. The use and management of in vitro diagnostics require technical knowledge, which is why instruments are used for diagnosis in specialized medical institutions.
IVD is medical equipment and accessories used to test samples such as blood, urine, and tissue samples to detect infection, prevent disease, monitor drug treatment, and diagnose health conditions. The introduction of new methods for rapid diagnosis of disease is expected to increase the demand for in vitro diagnostic.
The Covid-19 pandemic affected the demand and supply of Germany in-vitro diagnostics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Key Players Covered in the Report
- Hoffmann La Roche Ltd.; Epigenomics Inc.; Qiagen N.V; Abbott Laboratories; and Siemens Healthcare GmbH
Market Segment Insights
Based on test types, the in-vitro diagnostics market is divided into clinical chemistry, molecular diagnostics, immuno diagnostics, hematology, and others. The molecular diagnostics segment is expected to represent a key share of the market during the forecast period. Molecular diagnostics are used to analyze biomarkers of pathogens or changes in the genome and proteome. According to the technology used, molecular diagnostic equipment can be divided into chips and microarrays, mass spectrometry, next-generation sequencing methods, polymerase chain reaction methods, cytogenetic, and molecular imaging.
On the basis of products, the in-vitro diagnostics market is segregated into reagents, instruments, and others. The reagents segment is expected to hold a key share of the market during the forecast period. Increase in research and development of chronic disease diagnosis is one of the main driving forces for the development of reagent. Increasing number of IVD tests is one of the most important growth drivers in the field of reagents. On the other hand, the instrument segment is anticipated to expand at a rapid pace during the forecast period owing to the introduction of technologically advanced tools and rapid testing tools and rising aging population. In vitro diagnostics are expected to play an important role in diagnostics, such as blood glucose meters, chemical analyzers, clinical chemistry analyzers, blood analyzers, urine analyzers, and immunochemical analyzers.
In terms of usability, the in-vitro diagnostics market is bifurcated into disposable in-vitro devices and reusable in-vitro devices. The reusable in-vitro devices segment is expected to hold a key share of the market during the forecast period. Some reusable devices include forceps, stethoscopes, and endoscopes.
In terms of applications, the in-vitro diagnostics market is divided into autoimmune diseases, infectious devices, cardiology, nephrology, oncology, and others. The oncology segment is expected to represent a key share of the market during the forecast period. Growth of the market is attributed to high cost of several diagnostic platforms and rise in demand for IVD kits. The infectious disease segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing development & research procedures and changing lifestyles.
Get Sample Report @ Request For Sample of In-vitro Diagnostics Market – Germany Industry Analysis, Size, Share, Growth , Trends, and Forecast | Growth Market Reports
Based on end-users, the in-vitro diagnostics market is divided into hospitals, clinical laboratories, clinics, and others. The hospitals segment is expected to represent a key share of the market during the forecast period owing to increasing number of hospitals creating strong demand for in-vitro diagnostic testing. The demand for fast and accurate results from the biosensor, pregnancy kit and blood glucose meter is one of the main reasons for the rapid growth of the medical practice sector. Increasing use of equipment in hospitals and medical practices, especially in remote and rural areas, has stimulated demand for point-of-care testing, followed by an increase in doctors and hospital offices.
About Growth Market Reports:
Growth Market Reports provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com
Follow Us: LinkedIn | Twitter
0
